KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Work In Process (2016)

AbbVie has reported Work In Process over the past 5 years, most recently at $1.1 billion for Q2 2016.

  • Quarterly Work In Process rose 4.81% to $1.1 billion in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Jun 2016, up 4.81% year-over-year, with the annual reading at $1.1 billion for FY2015, 71.86% up from the prior year.
  • Work In Process was $1.1 billion for Q2 2016 at AbbVie, down from $1.1 billion in the prior quarter.
  • Over five years, Work In Process peaked at $1.1 billion in Q1 2016 and troughed at $262.0 million in Q1 2013.
  • The 5-year median for Work In Process is $568.0 million (2015), against an average of $672.0 million.
  • Year-over-year, Work In Process surged 122.85% in 2015 and then grew 4.81% in 2016.
  • A 5-year view of Work In Process shows it stood at $286.0 million in 2012, then skyrocketed by 41.26% to $404.0 million in 2013, then skyrocketed by 55.69% to $629.0 million in 2014, then skyrocketed by 71.86% to $1.1 billion in 2015, then fell by 1.2% to $1.1 billion in 2016.
  • Per Business Quant, the three most recent readings for ABBV's Work In Process are $1.1 billion (Q2 2016), $1.1 billion (Q1 2016), and $1.1 billion (Q4 2015).